B4GALT7 and hepatocellular carcinoma: Collectively, the above experiments demonstrated that shRNA mediated B4GALT7 suppression reduced cell proliferative, migrative and invasive abilities in vitro, and B4GALT7 acted as an oncogene in HCC.